eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Global Health
Team
Group Leader
Maria José Buzon and Israel Molina
Principal Investigator (PI)
Meritxell Genescà, Fernando Salvador, Adrian Sánchez, Nuria Serre, Inés Oliveira, Jordi Gómez, Marisa Aznar, Esperanza Esteban, Dolors Rodríguez Pardo, Òscar Len, Joan Gavaldà, Ibai Los Arcos, Vicenç Falcó, Joaquín Burgos, Jordi Navarro, Adrià Curran
Researchers
Núria Fernàndez Hidalgo, Adaia Albasanz, Maider Arando, Jorge Garcia, Vicence Descalzo, Patricia Alvarez, Silvina Magnani, Ana Gallego, Mireia Vives, Begoña Treviño, Diana Pou, Raisa Morales, Pepe Santos, Elena Trigo
PhD Students
Júlia Sellarés, Ester Márquez, Cristina Kirkegaard, Anna Falcó, Arnau Monforte, Paula Suanzes, Alba González, Oriol Ruiz, Diego González, Aleix Benitez, Pau Bosh, Juan Espinosa, Joan Martínez
Lab Technicians
Xavier Gomis
Nursing and Technical Staff
Rosa Badia, Bibiana Planas, Marta Sanchís, Raúl Muñoz, Claudia Broto, Luis López, Judith Grau, Hakima Ouaarab
Selected Publications
Kirkegaard-Biosca C, Del Barrio-Tofiño E, Villamarín M, Larrosa N, Campany D, González-López JJ, Ferrer R, Viñado B, Doménech L, Sellarès-Nadal J, Escolà-Vergé L, Fernández-Hidalgo N, Los-Arcos I.
Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.
Antibiotics (Basel). 2024 Sep 12;13(9):874
DOI: 10.3390/antibiotics13090874
IF: 4.3
Sempere A, Los-Arcos I, Sacanell J, Berastegui C, Campany-Herrero D, Vima J, Martín-Gómez MT, Sánchez L, Martínez-González D, Bravo C, Len O, Gavaldà J
Tobramycin Systemic Absorption in Lung Transplant Recipients Treated With Inhaled Tobramycin: A Cohort Study
Transpl Int. 2024 Mar 28;37:12579
DOI: 10.3389/ti.2024.12579
IF: 3.1
Burgos J, Curran A, Garcia J, Landolfi S, Hernández-Losa J, Suanzes P, Navarro J, Falcó V
Effectiveness of trichloroacetic acid versus electrocautery for the treatment of anal high-grade squamous intraepithelial lesions in persons with HIV
Infect Dis (Lond). 2024 Apr;56(4):299-307
DOI: 10.1080/23744235.2024.2303021
IF: 4
Sánchez-Gaona N, Gallego-Cortés A, Astorga-Gamaza A, Rallón N, Benito JM, Ruiz-Mateos E, Curran A, Burgos J, Navarro J, Suanzes P, Falcó V, Genescà M, Buzon MJ
NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV contro
JCI Insight. 2024 Sep 17;9(20):e182660
DOI: 10.1172/jci.insight.182660
IF: 6.3
Bosch-Nicolau P, Fernández ML, Sulleiro E, Villar JC, Perez-Molina JA, Correa-Oliveira R, Sosa-Estani S, Sánchez-Montalvá A, Del Carmen Bangher M, Moreira OC, Salvador F, Mota Ferreira A, Eloi-Santos SM, Serre-Delcor N, Ramírez JC, Silgado A, Oliveira I, Martín O, Aznar ML, Ribeiro ALP, Almeida PEC, Chamorro-Tojeiro S, Espinosa-Pereiro J, de Paula AMB, Váquiro-Herrera E, Tur C, Molina I
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial
Lancet Infect Dis. 2024 Apr;24(4):386-394
DOI: 10.1016/S1473-3099(23)00629-1
IF: 36.4
Selected Projects
Farmacocinética de antimicrobianos nebulizados: estudio “in vivo” en modelo murino y estudio piloto en receptores de trasplante pulmonar
Principal Investigator: Ibai Los Arcos
Agency: Insituto Salud Carlos III
Funding: 78,000 €
Period: 2023-2026
Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV
Principal Investigator: Maria Jose Buzon
Agency: "la Caixa” Foundation
Funding: 435,283 €
Period: 2021-2025
Estrategias de melhora dos ConHecimentos e Atitudes dos joveNs angolanos em matéria de saúde reproduCtiva e sExual (CHANCE)
Principal Investigator: Esperanza Esteban
Agency: Unión Europea (EuropeAid)
Funding: 1,018,000 €
Period: 2023-2027
Clinical Efficacy of oral Cefixime and Fosfomycin-Trometanol in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST)
Principal Investigator: Joaquín Burgos Cibrian
Agency: Instituto de Salud Carlos III
Funding: 180,000 €
Period: 2023-2025
Impact of early treatment during acute HIV infection on the metabolism of reservoir and immune effector cells: Identification of new targets to reduce persistent HIV
Principal Investigator: Jordi Navarro Mercadé
Agency: Instituto de Salud Carlos III
Funding: 87,120 €
Period: 2021-2025
Patents
BIOFILM PREVENTING SYSTEM FOR RESPIRATORY MEDICAL DEVICES
Priority Number: PCT/EP2021/074309
Priority Date: 23/07/2021
Applicants: Joan Gavaldà Santapau Marta Palau Gauthier Javier Gomis Rodríguez
SYSTEM FOR THERMOTHERAPY TREATMENT OR PREVENTION OF ANTIMICROBIAL RESISTANT OR BIOFILM INFECTIONS
Priority Number: PCT/IB2017/000186
Priority Date: 01/03/2016
Applicants: JOAN GAVALDA SANTAPAU, VICTOR FRANCO PUNTES, EDUARD TORRENTS SERRA
BI-FUNCTIONALIZED NANOPARTICLES, PROCESS FOR ITS PREPARATION AND USES THEREOF
Priority Number: PCT/EP2020/071635
Priority Date: 31/07/2020
Applicants: Maria José Buzón, Victor Franco Puntes, Antonio Astorga, Mireya Lopez
ENTRECTINIB AS ANTIVIRAL AGENT FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
Priority Number: PCT/EP2022/070594 22.07.2022
Priority Date: 23/07/2021
Applicants: Jana Selent, Alejandro Peralta, Maria José Buzón, Meritxell Genescà
Selected Dissemination Activities
Jornadas divulgación sobre salud sexual
Place: Benguela, Angola
Date: 25/09/2025
Brief: Different activities promoting sexual health
MORE INFO
